Nicholas Hoffman & Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$384K Hold
1,093
0.01% 258
2025
Q4
$358K Sell
1,093
-206
-16% -$65.3K 0.01% 257
2025
Q3
$367K Hold
1,299
0.01% 247
2025
Q2
$363K Buy
1,299
+126
+11% +$35.7K 0.01% 241
2025
Q1
$365K Hold
1,173
0.01% 225
2024
Q4
$306K Buy
1,173
+140
+14% +$41.5K 0.01% 236
2024
Q3
$333K Buy
1,033
+195
+23% +$63.8K 0.01% 242
2024
Q2
$262K Sell
838
-107
-11% -$31.4K 0.01% 257
2024
Q1
$269K Buy
945
+3
+0.3% +$878 0.01% 255
2023
Q4
$271K Buy
942
+2
+0.2% +$545 0.02% 240
2023
Q3
$253K Buy
940
+23
+3% +$5.74K 0.02% 231
2023
Q2
$204K Buy
917
+3
+0.3% +$696 0.01% 264
2023
Q1
$221K Buy
914
+86
+10% +$21.1K 0.02% 255
2022
Q4
$218K Buy
+828
New +$222K 0.02% 246
2022
Q3
Sell
-825
Closed -$201K 256
2022
Q2
$201K Buy
+825
New +$202K 0.01% 249
2021
Q4
Sell
-949
Closed -$202K 272
2021
Q3
$202K Buy
949
+1
+0.1% +$230 0.04% 254
2021
Q2
$231K Buy
948
+118
+14% +$29K 0.04% 239
2021
Q1
$207K Buy
+830
New +$198K 0.04% 236
2020
Q2
Sell
-1,342
Closed -$272K 201
2020
Q1
$272K Buy
1,342
+133
+11% +$29.1K 0.09% 145
2019
Q4
$292K Buy
1,209
+1
+0.1% +$220 0.08% 159
2019
Q3
$234K Buy
1,208
+1
+0.1% +$192 0.07% 169
2019
Q2
$222K Buy
1,207
+58
+5% +$10.4K 0.07% 170
2019
Q1
$218K Buy
+1,149
New +$219K 0.07% 166

Other funds holding AMGN

Nicholas Hoffman & Company's AMGN Position: Q1 2026 in Review

Nicholas Hoffman & Company held its Amgen (AMGN) position steady in Q1 2026 at 1,093 shares worth $384K. The position accounts for 0.01% of the portfolio, ranked #258.

Nicholas Hoffman & Company first reported a position in AMGN in Q1 2019 and has held it in 23 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Nicholas Hoffman & Company held 1,093 shares of Amgen worth $384K as of Q1 2026.
  • Nicholas Hoffman & Company left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.01% of Nicholas Hoffman & Company's portfolio in Q1 2026, its #258 holding.
  • Nicholas Hoffman & Company first reported a position in Amgen in Q1 2019 and has held it in 23 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q1 2026, filed 29 Apr 2026.